Molecular Partners Ag (MOLN) Current Deferred Revenue (2020 - 2023)
Molecular Partners Ag (MOLN) has disclosed Current Deferred Revenue for 1 consecutive years, with $6.7 million as the latest value for Q4 2022.
- On a quarterly basis, Current Deferred Revenue changed N/A to $6.7 million in Q4 2022 year-over-year; TTM through Dec 2022 was $6.7 million, a N/A change, with the full-year FY2022 number at $6.7 million, changed N/A from a year prior.
- Current Deferred Revenue was $6.7 million for Q4 2022 at Molecular Partners Ag.
- In the past five years, Current Deferred Revenue ranged from a high of $6.7 million in Q4 2022 to a low of $6.7 million in Q4 2022.